Bacteria isolated from companion animals in Japan (2014-2016) by blood culture

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Yuzo TsuyukiVeterinary Infection Control Association (VICA) Sepsis Working Group

Abstract

We aimed to identify microorganisms isolated by blood culture (BC) from companion animals and to determine antimicrobial resistance of these isolates during 2014-2016 at veterinary laboratory, in comparison with those during 2010-2013, in Japan. Clinical data (animal species, visiting animals/hospitalized animals, and others except for disease type and clinical course including history of antimicrobial agent use) on ill animals at veterinary clinics or hospitals were obtained. We retrospectively analyzed animal-origin BC results extracted from the database in 2014-2016 and those obtained in 2010-2013. BC-positive samples were from most of dogs (n = 174 in 2014-2016 and n = 86 in 2010-2013). Escherichia coli (n = 50, 25.1%) and Staphylococcus intermedius group (SIG) bacteria (n = 23, 11.6%) were most prevalent in 2014-2016, while the percentages of E. coli (n = 22, 25.3%) and SIG (n = 9, 10.3%) in 2010-2013 were similar to those in 2014-2016. Percentages of extended-spectrum β-lactamase (ESBL)-producing E. coli and methicillin-resistant staphylococci (MRS) rate of SIG bacteria isolated in 2014-2016 were 28.0% and 69.6% (vs. 22.7% and 44.4% in 2010-2013), respectively. Fourteen ESBL-producing E. coli in 2014-2016 were isolated fr...Continue Reading

Citations

Feb 6, 2020·Japanese Journal of Infectious Diseases·Hirotaka TakagiKenichiro Ito
Jul 2, 2021·EFSA Journal·UNKNOWN EFSA Panel on Animal Health and Welfare (AHAW)Julio Alvarez
Oct 5, 2021·Journal of Veterinary Emergency and Critical Care·Heidi K SaarenkariLisa Smart

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.